Heparan sulfate proteoglycans (HSPGs) play important roles in many biological events including amyloid plaque formation, viral infection, inflammation, and cancer development. HSPGs isolated from nature exist as a highly heterogeneous mixture due to the variable structures of the heparan sulfate side chains. Heparan sulfates are traditionally believed to dictate the functions of HSPGs. Recent studies have gained increasing evidence suggesting that both the glycan chains and the core peptides/proteins can be critical. Therefore, to thoroughly understand their functions, it is important to have access to HSPGs bearing homogeneous glycans. However, to date, no general synthetic methodologies are available to prepare this type of structures. In order to overcome this obstacle, in this application, novel methodologies will be developed to synthesize these highly challenging molecules, which will then be used to understand how HSPGs interact with amyloid . There are four aims in this application.
In aim 1, a chemical synthesis strategy will be established towards HSPG glycopeptides bearing one heparan sulfate chain. Suitable protective group and glycosylation chemistry has been developed demonstrating the feasibility of chemically synthesizing HSPG glycopeptides with one glycan chain.
In aim 2, a divergent approach will be established to modify HSPG glycopeptides with heparan sulfate biosynthetic enzymes. Promising preliminary results have been obtained suggesting enzymatic synthesis can be well integrated with chemical synthesis to enable the preparation of glycopeptides with diverse glycan structures from a common intermediate.
In aim 3, through a combination of chemical and enzymatic methods, HSPG glycopeptides bearing multiple glycan chains and extended peptide backbone will be produced. This will lead to glycopeptides approaching the full complexities of HSPGs.
In aim 4, using the synthetic heparan sulfate/HSPG glycopeptides, the structural features critical for their interactions with amyloid , the pathological hallmark f Alzheimer's disease, will be identified. The proposed studies will provide the unprecedented access to HSPGs containing homogeneous heparan sulfate glycans, which will lead to exciting opportunities for studies of their fascinating biological properties.

Public Health Relevance

Heparan sulfate proteoglycans are important for many biological processes. The overall goals of this project are to develop novel methods to synthesize structurally well-defined heparan sulfate glycopeptides. The availability of these complex structures can greatly expedite the understanding of their functions in the biological systems as exemplified by the study on how heparan sulfate glycopeptides interact with amyloid , a hallmark of Alzheimer's disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM072667-13
Application #
9435137
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Marino, Pamela
Project Start
2005-03-01
Project End
2019-02-28
Budget Start
2018-03-01
Budget End
2019-02-28
Support Year
13
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Michigan State University
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
193247145
City
East Lansing
State
MI
Country
United States
Zip Code
48824
Ramadan, Sherif; Yang, Weizhun; Zhang, Zeren et al. (2017) Synthesis of Chondroitin Sulfate A Bearing Syndecan-1 Glycopeptide. Org Lett 19:4838-4841
Yang, Weizhun; Yang, Bo; Ramadan, Sherif et al. (2017) Preactivation-based chemoselective glycosylations: A powerful strategy for oligosaccharide assembly. Beilstein J Org Chem 13:2094-2114
Yang, Weizhun; Yoshida, Keisuke; Yang, Bo et al. (2016) Obstacles and solutions for chemical synthesis of syndecan-3 (53-62) glycopeptides with two heparan sulfate chains. Carbohydr Res 435:180-194
Yang, Weizhun; Ramadan, Sherif; Yang, Bo et al. (2016) Homoserine as an Aspartic Acid Precursor for Synthesis of Proteoglycan Glycopeptide Containing Aspartic Acid and a Sulfated Glycan Chain. J Org Chem 81:12052-12059
Lu, Xiaowei; Huang, Xuefei (2015) Design and syntheses of hyaluronan oligosaccharide conjugates as inhibitors of CD44-Hyaluronan binding. Glycoconj J 32:549-56
Zhou, Wen; Hsieh, Po-Hung; Xu, Yongmei et al. (2015) Design and synthesis of active heparan sulfate-based probes. Chem Commun (Camb) 51:11019-11021
Dulaney, Steven B; Xu, Yongmei; Wang, Peng et al. (2015) Divergent Synthesis of Heparan Sulfate Oligosaccharides. J Org Chem 80:12265-79
Wang, Peng; Kouyoumdjian, Hovig; Zhu, David C et al. (2015) Heparin nanoparticles for ? amyloid binding and mitigation of ? amyloid associated cytotoxicity. Carbohydr Res 405:110-4
Wang, Peng; Nilsson, Jonas; Brinkmalm, Gunnar et al. (2014) Synthesis aided structural determination of amyloid-?(1-15) glycopeptides, new biomarkers for Alzheimer's disease. Chem Commun (Camb) 50:15067-70
Yoshida, Keisuke; Yang, Bo; Yang, Weizhun et al. (2014) Chemical synthesis of syndecan-3 glycopeptides bearing two heparan sulfate glycan chains. Angew Chem Int Ed Engl 53:9051-8

Showing the most recent 10 out of 32 publications